Clozapine Diminishes Suicidal Behavior: A Retrospective Evaluation of Clinical Records
J Clin Psychiatry 2005;66(4):534-538
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Objective: To test the antisuicidal effect of
clozapine, taking into consideration some potentially confounding
Method: A retrospective evaluation was conducted
of the clinical charts of 94 inpatients treated continuously with
clozapine for at least 6 weeks between 1962 and 1994. In a mirror
design, a period of continuous clozapine treatment (mean duration
of 15 months) was compared with a pre-clozapine period of equal
length, and in 17 patients also with a post-clozapine period,
with regard to suicidal behavior. The role of variables such as
staying in a protective hospital milieu and receiving treatment
with typical neuroleptics and antidepressants was considered.
Results: The rate of suicidal behavior was 28%
(26/94) in the pre-clozapine period, 3% (3/94) in the clozapine
period, and 18% (3/17) in the post-clozapine period, the
corresponding figures for serious suicidal behavior requiring
medical attention being 12% (11/94), 1% (1/94), and 12% (2/17),
respectively. The odds ratios were 11.6 (95% CI = 3.4 to 39.9) and
12.3 (95% CI = 1.6 to 97.5) for suicidal and serious suicidal
behavior, respectively, in favor of the clozapine period in
comparison with the pre-clozapine period. Staying in the hospital
was associated with reduction in suicidal behavior. The
antisuicidal effect of clozapine possibly disappears at doses
that are too low.
Conclusion: Clozapine diminishes the frequency
of suicidal behavior including serious suicidal acts, regardless
of comedication with antidepressants. In the protective hospital
milieu, this effect is less pronounced, and it disappears after